Liabilities / Assets
94th percentile
Higher debt load relative to assets than 94% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.82x
Liabilities / Revenue
97th percentile
Higher debt load relative to revenue than 97% of similar nonprofits.
Net Margin
89th percentile
Higher net margin than 89% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
90th percentile
Faster asset growth than 90% of similar nonprofits.
Revenue Growth
95th percentile
Faster revenue growth than 95% of similar nonprofits.
Balance Sheet
Assets
Up$364,209
Up $152,316 (+72%) from 2022
Net Assets
Up$66,116
Up $97,745 (+309%) from 2022
Liabilities
Up$298,093
Up $54,571 (+22%) from 2022
Revenue And Expenses
Revenue
Up$225,448
Up $153,233 (+212%) from 2022
Expenses
Up$127,701
Up $15,179 (+13%) from 2022
Net Income
Up$97,747
Up $138,054 (+343%) from 2022
Historical Trend
Filing Detail Status
This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview
Mission
Providing supplements and support for ill patients with sensitive immune systems, and providing financial support for organizations who align with the same mission
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2023 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $364,209
- Liabilities
- $298,093
- Net assets
- $66,116
- Revenue
- $225,448
- Expenses
- $127,701
- Net income
- $97,747